Saturday December 16, 2017 04:29

Food and Healthcare Press Releases

ESMO Publishes New Position Paper on Supportive and Palliative Care Heathcare—15 Dec 17

ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care [ https://doi.org/10.1093/annonc/mdx757 ], calling attention to the evolving and growing gap between the needs of cancer

Koch Disruptive Technologies to Lead $150 Million Investment of INSIGHTEC Heathcare—15 Dec 17

The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies,

MediaTek Sensio: New Biosensor Solution Brings Health Monitoring to Heathcare—15 Dec 17

MediaTek Inc. today unveiled MediaTek Sensio(TM), the first 6-in-1 smartphone biosensor module. MediaTek Sensio is a powerful advanced health monitoring solution which makes it easy to track heart rate information, blood pressure trends, peripheral

Merck Signs Distribution Agreement with Avanti(R) Polar Lipids Heathcare—12 Dec 17

Merck , a leading science and technology company, today announced that it has entered into an agreement with Avanti(R) Polar Lipids to be the exclusive multinational distributor of the USA-based company's research lipids portfolio outside of the United

Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for Heathcare—12 Dec 17

Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes after six months.[1] The study looked at people with type 2

Tresiba(R) Reduces Hypoglycaemia Regardless of Blood Sugar Level Heathcare—07 Dec 17

People with either type 1 or type 2 diabetes treated with Tresiba(R) had fewer episodes of low blood sugar (hypoglycaemia) compared with people on insulin glargine U100 regardless of whether they had achieved blood sugar targets.[1] These new post-hoc

Ryzodeg(R) Significantly Reduces the Risk of Low Blood Sugar in People With Type 2 Diabetes who Heathcare—07 Dec 17

In people with type 2 diabetes who fast during Ramadan, Ryzodeg(R) (insulin degludec/insulin aspart) reduced the overall rate of low blood sugar (hypoglycaemia) including severe episodes by 62% and the rate of nocturnal hypoglycaemia by 74% versus

Interim Results of First-Ever Global Survey Show People with Type 2 Diabetes Underestimate their Heathcare—06 Dec 17

- Globally, cardiovascular disease (CVD) is the most common cause of death in people with type 2 diabetes[1] - 1 in 3 respondents considered themselves to be at low risk of CVD[2] - 1 in 6 respondents had never discussed type 2 diabetes and

JOHNSON JOHNSON THAILAND PROVIDES HOLISTIC DIABETES CARE SOLUTIONS WITH NEW IN-STORE PROGRAM AT Heathcare—06 Dec 17

Johnson & Johnson (Thailand) Limited marked World Diabetes Day this month by launching a new in-store holistic diabetes care program at FASCINO, one of the leading pharmacy chains operating in Thailand. The program aims to provide access to diabetes

Switching to Tresiba(R) Benefits People with Diabetes Irrespective of Blood Sugar Levels in a Heathcare—06 Dec 17

- Switching to Tresiba(R) reduced the rate of hypoglycaemia by 67% in people with controlled blood sugar levels - In people with diabetes whose blood sugar was too high, switching to Tresiba(R) significantly improved blood sugar levels Switching to

Merck Announces FDA 510(k) Clearance of Partner Genea Biomedx#s Fertility Benchtop Incubator Heathcare—06 Dec 17

- Expanded Fertility Technology portfolio highlights Merck's commitment to improve fertility treatment outcomes for patients - U.S. commercial availability expected in first half of 2018 Merck, a leading science and technology company, today announced

Miniaturized Surgical Robotic Instruments Expand the Possibilities of Surgical Heathcare—06 Dec 17

Medical Microinstruments S.r.l. (MMI), a developer of novel robotic solutions for unmet medical needs, today reveals its robotic platform specifically designed for open microsurgery. The platform allows the surgeon to control two tiny articulated

Xultophy(R) Reported a Better Option than Basal-Bolus Insulin Therapy to Manage Type 2 Diabetes by Heathcare—06 Dec 17

Once-daily Xultophy(R) (insulin degludec/liraglutide) was a better option to manage diabetes compared to multiple daily injections of insulin (basal-bolus regimen). This was reported by people with type 2 diabetes whose blood sugar was not controlled on

Xultophy(R) Offers Greater Blood Sugar and Body Weight Reductions in People With Type 2 Diabetes, Heathcare—04 Dec 17

New findings from an indirect comparison between Xultophy(R) and IGlarLixi published in the Journal of Medical Economics show that treatment with Xultophy(R) (insulin degludec/liraglutide) provides statistically significant greater reductions in blood

5 Tips to Stay Healthy During the Festive Season Heathcare—01 Dec 17

With New Year just around the corner, it's the best time to celebrate with loved ones and indulging in guilty-pleasure foods. Because let's be honest, when it comes to celebrating, healthy eating might not be the priority. But with some smart and simple

Photo Release: The Department of Disease Control (DDC), the Ministry of Public Heathcare—01 Dec 17

SOFFELL Enesis Group and Dr. Prawit Wairungruangkul (4th person from left), Managing Director of CP Consumer Products Co., Ltd., together with the company's executives gave Soffell mosquito repellents, value at 1,728,000 baht in total, to the Department

Jubilant Biosys Announces Successful Achievement of an Early Milestone Related to One of Their Heathcare—29 Nov 17

Jubilant Biosys Ltd. , a Bengaluru-based subsidiary of Jubilant Life Sciences Ltd., announced today that they successfully achieved an early-stage milestone related to a collaborative program with Sanofi in Frankfurt, Germany focused on metabolic

Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Heathcare—29 Nov 17

- Pivotal Phase III Javelin trial investigating avelumab as third-line treatment for patients with unresectable, recurrent or metastatic gastric cancer did not meet its pre-specified primary endpoint of superior overall survival compared to

Insightec: The Taiwanese Food and Drug Administration (TFDA) Approved Exablate Neuro for the Heathcare—29 Nov 17

INSIGHTEC , the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced today that the Taiwanese Food and Drug Administration (TFDA) has approved its Exablate Neuro system for the treatment of essential tremor in patients who do not respond to

China successfully completes the country#s first human implantation of a retrievable transcatheter Heathcare—29 Nov 17

- The success of the procedure unleashes a new era for retrievable interventional cardiac valve technology in China The first human implantation of the VenusA Plus retrievable valve system was completed successfully at the Second Affiliated Hospital of

Giving Back Made Easy with Smile Train#s New Campaign Heathcare—29 Nov 17

Smile Train launches 'Give Smiles' Campaign on biggest giving day of the year, Giving Tuesday to support children with untreated clefts around the world In celebration of Giving Tuesday and the season of giving, Smile Train, the world's largest cleft

WIRB-Copernicus Group Acquires Vigilare International Heathcare—29 Nov 17

WIRB Copernicus Group(R) (WCG(TM)), the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of Vigilare International, the top provider of integrated, end-to-end

Beckman Coulter Enters Commercial Dispute with Quidel to Sell BNP Directly Heathcare—28 Nov 17

Beckman Coulter is committed to ensuring customers receive the highest quality assays, on-time, to help healthcare and laboratory professionals provide better patient care. To further these goals, Beckman Coulter plans in the future to sell directly to

Distinguished Doctors Converged at Royal Cliff and PEACH for the 39th Annual Meeting of the Royal Heathcare—28 Nov 17

The award-winning Royal Cliff Hotels Group and Pattaya Exhibition And Convention Hall (PEACH) was once again the chosen venue for the 39th Annual Meeting of Royal College of Orthopedic Surgeons of Thailand (RCOST). RCOST spent 4 days at the award-winning